RWE was essential in understanding and fighting COVID-19, now it must be used to accelerate cancer research
Three reasons why we must continue utilising RWE post-pandemic:
- RWE studies represent real-world patient populations in real-life settings
- RWE can elevate patient-centricity (e.g. patient reported outcomes on quality of life)
- RWE studies identify significant findings more quickly
Click here to learn more.
SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.